Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1983 1
1993 1
1996 1
1997 1
2000 1
2001 3
2004 2
2007 1
2010 1
2012 1
2013 3
2015 1
2017 2
2018 1
2019 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Social support and religion: mental health service use and treatment of schizophrenia.
Smolak A, Gearing RE, Alonzo D, Baldwin S, Harmon S, McHugh K. Smolak A, et al. Community Ment Health J. 2013 Aug;49(4):444-50. doi: 10.1007/s10597-012-9536-8. Epub 2012 Aug 2. Community Ment Health J. 2013. PMID: 22855264 Free PMC article. Review.
The perceptions and religious beliefs held by family members, mental health and health care professionals, and the community may affect the treatment of individuals with schizophrenia. To better identify and understand the influence of families, professionals and co …
The perceptions and religious beliefs held by family members, mental health and health care professionals, and the community may affe …
Understanding healthcare burden and treatment patterns among young adults with schizophrenia.
Huang A, Amos TB, Joshi K, Wang L, Nash A. Huang A, et al. J Med Econ. 2018 Oct;21(10):1026-1035. doi: 10.1080/13696998.2018.1500370. Epub 2018 Jul 27. J Med Econ. 2018. PMID: 30001651 Free article.
AIMS: To examine treatment patterns and evaluate healthcare resource utilization (HRU) and costs among young adults (18-35 years) with schizophrenia who were early in the disease. MATERIALS AND METHODS: Patients aged 18-64 years with 2 schizophrenia diagnoses …
AIMS: To examine treatment patterns and evaluate healthcare resource utilization (HRU) and costs among young adults (18-35 years) with sc
Diagnostic progression to schizophrenia in 35,255 patients with obsessive-compulsive disorder: a longitudinal follow-up study.
Chen MH, Tsai SJ, Liang CS, Cheng CM, Su TP, Chen TJ, Bai YM. Chen MH, et al. Eur Arch Psychiatry Clin Neurosci. 2023 Apr;273(3):541-551. doi: 10.1007/s00406-021-01361-w. Epub 2022 Mar 24. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 35332401
Evidence suggests a continuity between obsessive-compulsive disorder (OCD) and schizophrenia. However, the factors that may predict diagnostic progression from OCD to schizophrenia remain unclear. ...Male sex (hazard ratio: 1.23), obesity (1.77), autism spectrum dis …
Evidence suggests a continuity between obsessive-compulsive disorder (OCD) and schizophrenia. However, the factors that may predict d …
Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia.
Fenton WS, Hibbeln J, Knable M. Fenton WS, et al. Biol Psychiatry. 2000 Jan 1;47(1):8-21. doi: 10.1016/s0006-3223(99)00092-x. Biol Psychiatry. 2000. PMID: 10650444 Review.
Recent research suggests that deficient uptake or excessive breakdown of membrane phospholipids may be associated with schizophrenia. We review available clinical research on abnormalities in membrane fatty acid composition and metabolism in schizophrenia, and th
Recent research suggests that deficient uptake or excessive breakdown of membrane phospholipids may be associated with schizophrenia. …
Treatment of the schizophrenia prodrome: is it presently ethical?
Cornblatt BA, Lencz T, Kane JM. Cornblatt BA, et al. Schizophr Res. 2001 Aug 1;51(1):31-8. doi: 10.1016/s0920-9964(01)00236-5. Schizophr Res. 2001. PMID: 11479063 Review.
Although the devastating consequences of schizophrenia have long been known, interest in preventive intervention has only recently emerged. ...In particular, it is essential to establish solid base rates for schizophrenia in prodromal individuals before early treatm …
Although the devastating consequences of schizophrenia have long been known, interest in preventive intervention has only recently em …
Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice.
Fagiolini A, Aguglia E, Ballerini A, Callista G, Carpiniello B, Clerici M, Corrivetti G, De Fazio P, De Filippis S, De Giorgi S, Favaretto G, Ferri E, Gargiulo G, Giustra MG, La Barbera D, Maina G, Mencacci C, Montagnani G, Panariello A, Pigato G, Tortorella A, Vernacotola L, Vita A. Fagiolini A, et al. Psychiatry Res. 2019 Feb;272:698-706. doi: 10.1016/j.psychres.2019.01.012. Epub 2019 Jan 4. Psychiatry Res. 2019. PMID: 30832189
OBJECTIVES: To identify the variables that are associated with persistence to Aripiprazole-Long Acting (A-LAI), in adult patients with schizophrenia. METHODS: Observational, retrospective, non-interventional study involving 261 patients with schizophrenia. ...A-LAI …
OBJECTIVES: To identify the variables that are associated with persistence to Aripiprazole-Long Acting (A-LAI), in adult patients with sc
AMPA receptor potentiators for the treatment of CNS disorders.
O'Neill MJ, Bleakman D, Zimmerman DM, Nisenbaum ES. O'Neill MJ, et al. Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3):181-94. doi: 10.2174/1568007043337508. Curr Drug Targets CNS Neurol Disord. 2004. PMID: 15180479 Review.
Clinical and experimental data have suggested that positive modulation of AMPA receptors may be therapeutically effective in the treatment of cognitive deficits. Several classes of AMPA receptor potentiators have been reported, including pyrroliddones (piracetam, aniraceta …
Clinical and experimental data have suggested that positive modulation of AMPA receptors may be therapeutically effective in the trea …
Obsessive-compulsive symptoms in schizophrenia: their relationship with clinical features and pharmacological treatment.
Nolfe G, Milano W, Zontini G, Petrella C, De Rosa M, Rundle-Smith S, Nolfe G. Nolfe G, et al. J Psychiatr Pract. 2010 Jul;16(4):235-42. doi: 10.1097/01.pra.0000386909.84289.ee. J Psychiatr Pract. 2010. PMID: 20644358
OBJECTIVES: The aim of this study was to evaluate (1) the frequency of obsessive-compulsive symptoms (OCS) in patients with schizophrenia, (2) the impact of OCS on clinical features of schizophrenia, and (3) the association between type of antipsychotic treat …
OBJECTIVES: The aim of this study was to evaluate (1) the frequency of obsessive-compulsive symptoms (OCS) in patients with schizophrenia
The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003.
Lehman AF, Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB, Goldberg R, Green-Paden LD, Tenhula WN, Boerescu D, Tek C, Sandson N, Steinwachs DM. Lehman AF, et al. Schizophr Bull. 2004;30(2):193-217. doi: 10.1093/oxfordjournals.schbul.a007071. Schizophr Bull. 2004. PMID: 15279040
Since publication of the original Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations in 1998, considerable scientific advances have occurred in our knowledge about how to help persons with schizophrenia. ...Nonetheless, major challenges re …
Since publication of the original Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations in 1998, considerable …
Risperidone in the treatment of children and adolescents with schizophrenia: a retrospective study.
Grcevich SJ, Findling RL, Rowane WA, Friedman L, Schulz SC. Grcevich SJ, et al. J Child Adolesc Psychopharmacol. 1996 Winter;6(4):251-7. doi: 10.1089/cap.1996.6.251. J Child Adolesc Psychopharmacol. 1996. PMID: 9231318
Risperidone is a newly available atypical antipsychotic agent that has been reported to be associated with fewer extrapyramidal side effects (EPS) than conventional neuroleptics in adults with schizophrenia. This study assessed the safety and efficacy of risperidone in 16 …
Risperidone is a newly available atypical antipsychotic agent that has been reported to be associated with fewer extrapyramidal side effects …
22 results